Short Interest in NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) Increases By 300.0%

NRx Pharmaceuticals, Inc. (NASDAQ:NRXPW) was the target of a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 5,200 shares, an increase of 300.0% from the September 30th total of 1,300 shares. Based on an average trading volume of 4,300 shares, the short-interest ratio is presently 1.2 days.

NRx Pharmaceuticals Stock Performance

NRXPW remained flat at $0.05 during midday trading on Friday. The company’s stock had a trading volume of 10,779 shares, compared to its average volume of 16,955. NRx Pharmaceuticals has a 12-month low of $0.04 and a 12-month high of $0.39. The company’s 50 day simple moving average is $0.06 and its 200-day simple moving average is $0.08.

NRx Pharmaceuticals Company Profile

NRx Pharmaceuticals, Inc, a clinical-stage biopharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. Its products include NRX-101 (D-cycloserine/Lurasidone), an oral, fixed dosed combination of D-cycloserine and lurasidone that earned FDA-designated breakthrough therapy for suicidal treatment-resistant bipolar depression; and NRX-100 (ketamine), which has been awarded FDA fast track designation for the treatment of severe bipolar depression with acute suicidal ideation and behavior.